0000093314-14-000007.txt : 20141121 0000093314-14-000007.hdr.sgml : 20141121 20141121160248 ACCESSION NUMBER: 0000093314-14-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141121 DATE AS OF CHANGE: 20141121 EFFECTIVENESS DATE: 20141121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VOLITIONRX LTD CENTRAL INDEX KEY: 0000093314 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 911949078 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-228872 FILM NUMBER: 141243010 BUSINESS ADDRESS: STREET 1: 150 ORCHARD ROAD CITY: ORCHARD PLAZA 08-02 STATE: U0 ZIP: 238841 BUSINESS PHONE: 000-000-0000 MAIL ADDRESS: STREET 1: 150 ORCHARD ROAD CITY: ORCHARD PLAZA 08-02 STATE: U0 ZIP: 238841 FORMER COMPANY: FORMER CONFORMED NAME: STANDARD CAPITAL CORP DATE OF NAME CHANGE: 19990812 D 1 primary_doc.xml X0707 D LIVE 0000093314 VOLITIONRX LTD 1 Scotts Road #24-05 Shaw Centre Singapore U0 SINGAPORE 228208 6466501351 DELAWARE STANDARD CAPITAL CORP Corporation true Cameron Reynolds 1 Scotts Road #24-05 Shaw Centre Singapore U0 SINGAPORE 228208 Executive Officer Director President, Chief Executive Officer & Director Mike O'Connell 1 Scotts Road #24-05 Shaw Centre Singapore U0 SINGAPORE 228208 Executive Officer Chief Financial Officer Rodney Gerard Rootsaert 1 Scotts Road #24-05 Shaw Centre Singapore U0 SINGAPORE 228208 Executive Officer Secretary Martin Faulkes 1 Scotts Road #24-05 Shaw Centre Singapore U0 SINGAPORE 228208 Director Guy Archibold Innes 1 Scotts Road #24-05 Shaw Centre Singapore U0 SINGAPORE 228208 Director Alan Colman 1 Scotts Road #24-05 Shaw Centre Singapore U0 SINGAPORE 228208 Director Habib Skaff 1 Scotts Road #24-05 Shaw Centre Singapore U0 SINGAPORE 228208 Director Biotechnology Decline to Disclose 06b false 2014-11-17 false true false 0 GVC Capital LLC 38923 None None 5350 Roslyn Street Suite 400 Greenwood Village CO COLORADO 80111 CO COLORADO OK OKLAHOMA false 721849 721849 0 false 21 57000 0 GVC Capital shall receive a commission of $57,000 calculated as 8% of the total investment ($712,504) raised by GVC and warrants to purchase up to 19,000 common stock shares at an exercise price of $3.75 per share and expiry date 3 years after issuance. 0 false VOLITIONRX LTD Cameron Reynolds Cameron Reynolds CEO, President & Director 2014-11-21